Neurofit is pleased to announce its participation at BIO-EUROPE 2007 from November 12 to 14, 2007, Hamburg, Germany.
If you are attending the meeting, our CEO, Dr Frank Sams-Dodd will be very pleased to meet with you to discuss possible areas of collaboration.
Neurofit is a preclinical CRO offering in vitro and in vivo drug screening services in the area of pain, psychiatry, neurology, multiple sclerosis and oncology.
For more information and details of our screening tests, please click on the link below.